Wednesday, January 27, 2021

FinovateEurope Conference Keeps Pace with Essential Fintech Innovation as Pandemic Continues

 

  • What: FinovateEurope is a virtual gathering of fintech innovators and financial institutions focused on the European continent
  • When: March 23-25, 2021 scheduled for the Central European Time zone, but with 24-hour live and on-demand access to accommodate a global attendance
  • More than 50 expert speakers and over 25 product demos, as well as over a thousand senior decision makers from fintech-related businesses
  • A diversity of networking opportunities, whether through real-time Q&A sessions, one-on-one meetings, virtual coffee chats and small group get-togethers

The Internet revolution that occurred a generation ago made networking the lifeblood of today’s technology and gave global economies a rosier complexion as more vitality began to course through the business world in a similar vein.

This year’s FinovateEurope continues the event series’ investment in connecting seasoned business professionals and new innovators from across the globe in a peer building exercise focused on the continent known as the cultural root of Western civilization.

FinovateEurope in 2021 promises to draw 1,000-plus senior decision makers and fintech influencers to create 1,000-plus business opportunities (https://nnw.fm/b1yz5). Representatives of some of the world’s largest banks, from Silicon Valley Bank to Eurobank, will join forces with upstart technology developers for three days of problem solving and resource-building in the capital finance arena.

The action begins March 15 when organizers open their doors to attendees interested in Finovate’s on-demand content, which includes the Startup Booster program and behind-the-scenes access to the series’ speakers.

The event kicks off in earnest a week later on March 23 when the full body of attendees join for opening exercises and the launch of the series’ conference and roundtable streams. The keynote address sets the theme, noting how the COVID pandemic has made it apparent that digital connectivity is no longer merely a nice tool to have, but an essential underpinning of business, and the importance of building on that proof of concept to make it part of company culture.

As a result of the pandemic, all of the conference events will be held in a virtual online world, which is right up the fintech industry’s alley on a day-to-day basis. The virtual format transcends national barriers and eliminates the burden of long-distance travel that can complicate attendance for those who are interested in the insights FinovateEurope’s speakers can share.

The conference schedule is organized on the Central European Time zone (GMT+1) but networking activity will take place on a 24-hour basis in recognition of the event’s global nature, with content available either live or on-demand.

The agenda features more than 50 speakers and over 25 product demos. As networking gives the event life, participants can engage with speakers in real time in a Q&A format and other attendees through one-on-one meetings, virtual coffee chats and small group chats, all with the flexibility of a platform that allows participants to arrange impromptu get-togethers through their digital devices.

Finovate’s research and advisory team has been organizing similar events since 2007, and has reassessed every aspect of the program to ensure that the digital-only gathering will provide participants with the best value since last year’s European event was one of the first conferences to move online in response to the global health crisis.

For more information and to order tickets or book a spot as a demoer or speaker, visit the event’s website at https://informaconnect.com/finovateeurope/.

Here is your 20 percent discount code: FKV2378NNW

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Discusses Product Pipeline, Clinical Trial Plans, at H.C. Wainwright Bioconnect 2021 Virtual Conference

 

  • Company will initiate a Phase II adult trial for Berubicin this year focused on patients with glioblastoma multiforme
  • WPD, a CNS sub-license partner, will be commencing a parallel Phase II adult trial and the first-ever pediatric Berubicin trial
  • Additional clinical trials are in the pipeline, including one for the company’s newest drug candidate, WP1244, and its effects on central nervous system tumors

Biopharmaceutical company CNS Pharmaceuticals (NASDAQ: CNSP) recently took part in the H.C. Wainwright Bioconnect 2021 Virtual Conference, which took place January 11-14, 2021. CNS’s CEO John Climaco gave a presentation at the event, discussing how the clinical-stage biopharmaceutical company is developing novel treatments for primary and metastatic cancers of the brain and central nervous system (https://nnw.fm/KOU9r).

CNS’s lead drug candidate is Berubicin, an anthracycline that, based on clinical data, can cross the blood-brain barrier in adults and reach the tumor cells of patients with brain cancer. As an organ targeted therapeutic, Berubicin demonstrated one durable complete response (not detectible on imaging) in a Phase I trial completed by Reata Pharmaceuticals, Inc. (NASDAQ: RETA) 14 years ago. CNS currently holds the worldwide exclusive licensing to the Berubicin drug and it recently obtained Investigational New Drug designation for it from the Food and Drug Administration.

In addition to Berubicin, the company’s current developmental pipeline includes a second promising drug candidate, WP1244. Licensed from The University of Texas MD Anderson Cancer Center in the first quarter of 2020, WP1244 is a DNA-binding agent that represents a novel class of potential therapeutics.

WP1244 is designed using anthracycline and distamycin-based scaffolds, creating small molecule agents binding extended sequences of DNA. In vivo testing demonstrated high uptake with WP1244 in the brain and subsequent antitumor activity in orthotopic models of the brain. The drug candidate is believed to be 500 times more potent than daunorubicin in inhibiting tumor cell proliferation. CNS entered into a Sponsored Research Agreement with MD Anderson Cancer Center in May 2020, related to WP1244.

CNS Pharmaceuticals, in partnership with company sublicensee WPD Pharmaceuticals, Inc. (CSE: WBIO) (FSE: 8SV1) currently has several clinical trials in different stages of preparation, including three glioblastoma multiforme (“GBM”) studies for Berubicin, scheduled to begin in Q1 2021. These include a randomized, controlled Phase II trial in the United States and another Phase II in Poland, conducted by WPD. Both these studies will be conducted with adult candidates. WPD will also begin the first-ever Phase I pediatric trial with Berubicin in Poland. Other studies in the pipeline for a future date include a potential Phase I trial for Berubicin with pancreatic and ovarian cancer and lymphoma patients as well as a potential Phase I trial for WP1244 for central nervous system tumors.

The primary focus for Berubicin has been patients with GBM, one of the most aggressive forms of brain cancer currently considered incurable. Each year, nearly 15,000 new GBM patients are being diagnosed in the United States. With the optimal therapy (surgical resection, chemotherapy, radiation), the median survival rate is only 15-23 months. Nearly 100% of GBM tumors recur after first-line therapy.

The Phase II trials for Berubicin in adult candidates are designed to be:

  • Adaptive – the trial is designed to allow for modifications based on accumulated data from trial subjects
  • Randomized – the trial randomizes which patients receive Berubicin versus the control group, eliminating the bias and increasing statistical significance
  • Controlled – a control arm receiving the standard of care to compare the effectiveness of Berubicin against this standard, increasing the statistical significance
  • Potentially Pivotal – the trials are designed to provide, pending positive results, the data necessary to support CNS’s request to the FDA for an expedited pathway to further development or approval of Berubicin

CNS believes that Berubicin has the potential to become a standard of care for GBM and other forms of brain cancer. The current first-line therapy includes temozolomide (“TMZ”). Nearly 40% of patients are genetically predisposed to respond to, becoming resistant to the treatment quickly. Berubicin could potentially be a second-line drug in these cases. The remaining 60% of patients may not be affected by TMZ, making Berubicin a potential first choice.

At the close of the presentation, Climaco said the company expects to see the first data for the Phase II trial in Poland reported during the third or fourth quarter of this year.

For more information, visit the company’s website at www.CNSPharma.com

NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at https://nnw.fm/CNSP

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Green Hygienics Holdings (GRYN) Leverages FDA Registration, USDA/CCOF Certification as Powerful Competitive Differentiator

 

  • Green Hygienics poised to become most highly certified hemp company in industry to differentiate itself from competition
  • Anticipating tightening of regulatory standards, GRYN already achieved FDA registration and USDA/CCOF certification proving highest standards of product quality, transparency and safety
  • With certifications to prove high-quality products, Green Hygienics appears ideally positioned to offer growth potential in increasingly quality-aware market

As an innovative technology-driven enterprise, Green Hygienics Holdings (OTCQB: GRYN) is dedicated to delivering the highest operating standards of industrial hemp cultivation and processing, and manufacturing of pharmaceutical-grade bioactive cannabinoids. Poised to bring safe and consistent products to market and thus change the industry’s landscape and enhance consumer confidence, GRYN is committed to becoming the most highly certified hemp company in the industry (https://nnw.fm/yzOPL). 

Last year was a year of success for Green Hygienics as the company achieved important milestones that lie at the heart of its value proposition. The first is registration with the U.S. Food and Drug Administration, which enhances GRYN’s core mission to provide processing and product safety, transparency and reliability both to consumers and the pharmaceutical industry. 

The second is the USDA Organic Certification (7 CFR Part 205) issued by the California Certified Organic Farmers, which allows Green Hygienics to cultivate and process post-harvest industrial hemp and supply certified organic hemp products to national and international markets from its Sol Valley Ranch property. With its 824-acre hemp farm, including 400,000 square feet of indoor greenhouse space, GRYN has become the largest single USDA-certified organic hemp farm in North America (https://nnw.fm/sGAiK). 

Green Hygienics appears ideally positioned to remain on the research-based innovation path and drive new product commercialization fully complaint to USDA and FDA regulatory requirements. The company intends to rationally design and deliver novel fit-for-purpose cannabinoids and targeted bio-delivery technologies, using cutting-edge technology to solve the issues of product stability, pharmacokinetics, biological tissue distribution and systemic bioavailability to improve the lives of billions.

With an emerging push in the market as consumers ask for safe and efficacious products while industries such as medical, nutraceutical and pharmaceutical are seeking a secure supply chain, product quality and product associated evidence-based functionality become strong differentiators among medical practitioners and customers. The company that can address these unmet market needs could be well-placed to secure a strategic advantage in the marketplace and Green Hygienics looks poised to achieve precisely that and to become a leader in compliances and capabilities in the hemp and cannabinoid supply marketplace.

As GRYN intends to become the most highly certified hemp company in the industry, it presents investors with an opportunity to invest in a company that uniquely positions itself as a trusted source that delivers safe and premium quality products to consumers and to CPG (consumer-packaged-goods) and pharmaceutical companies. With certifications to prove the highest operating standards, Green Hygienics seems well-positioned to offer growth potential in a market that is becoming increasingly quality-aware.

For more information, visit the company’s website at www.GreenHygienics.com.

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://nnw.fm/GRYN

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Censorship and Data: The Stakes and Consequences Are Getting Serious

 NetworkNewsWire Editorial Coverage: A recent Pew Research article pinpointed major concerns with social media platforms. “Americans have complicated feelings about their relationship with big technology companies,” the article observes. “While they have appreciated the impact of technology over recent decades and rely on these companies’ products to communicate, shop and get news, many have also grown critical of the industry.” The article goes on to report that a Pew Research Center survey found that “roughly three-quarters of U.S. adults say it is very (37%) or somewhat (36%) likely that social media sites intentionally censor political viewpoints that they find objectionable. Just 25% believe this is not likely the case.” The events of the last few weeks have made that article appear almost prophetic as issues of censorship and privacy have gained additional prominence on the world stage. A number of private and public companies are working to resolve these issues, with many of those companies relying on blockchain to provide their services. Leading the pack is BIGtoken, the first consumer-managed data marketplace where people can own and earn from their data. The opportunity ahead has such potential that parent company SRAX Inc. (NASDAQ: SRAX) is spinning out BIGtoken into a separate publicly traded company and has entered into a definitive share exchange agreement with Force Protection Video Equipment Corp. (OTC: FPVD). The separation of BIGtoken provides shareholders a pure play in the consumer-managed data sector. SRAX benefits from the potential upside of the BIGtoken platform while reducing operating costs. Social media behemoths such as Facebook Inc. (NASDAQ: FB) and Twitter Inc. (NYSE: TWTR) are under pressure to identify and remove hate-filled communication along with taking added measures to protect consumer data. Blockchain companies such as Riot Blockchain Inc. (NASDAQ: RIOT) could benefit from increased implementation of blockchain technology to protect consumers, safeguard information and ensure data privacy. Everyone’s at risk as revealed by the recent Solarwinds hack, which compromised not just local, state and federal agencies but also major tech companies as well.

  • Consumers starting to more deeply question growing censorship issues, lack of data control.
  • Using blockchain, BIGtoken is first consumer-managed data marketplace where users can own, earn from their data.
  • BIGtoken CEO writes that Privacy is fundamental human right whose time has come, and BIGtoken is pioneering the way forward.

Growing Concerns Surrounding Censorship, Privacy

Large social media sites now wield enormous power as they have become the dominant platforms of opinion and information. As they grew, they have used their codes of conduct to restrict certain opinions which is causing consumers to be acutely aware of the value of their personal data and driving them to alternative networks.

The issue of censorship on social media sites has never been more compelling — or divisive. A Jan. 14, 2021, Harvard Business Review article reported that “after years of controversy over President Trump’s use of social media to share misleading content and inflame his millions of followers, social media giants Facebook and Twitter finally took a clear stand last week, banning Trump from their platforms — Facebook indefinitely, and Twitter permanently.

“Could this indicate a turning point in how social media companies handle potentially harmful content shared on their platforms? And could it herald a new era of social media reforms, through both government policies and self-regulation? For many, Facebook and Twitter’s bans were long-awaited. But it’s not so cut and dry, as many others have decried these decisions as infringements on free speech.”

An “Observer Research Foundation” article stated that social media “is facing increasing pressure from both politicians and activists throughout the world as fake news and propaganda have found a fertile ground on these new platforms.” The article notes that “tech giants are trapped in a tricky dilemma — how to save freedoms on the Internet and limitedly restrict them at the same time, and how not to overreact. . . . Tagging controversial posts with warnings and blocking radical points of views — seem to be reasonable in today’s world.”

Censorship is a matter of perspective depending which side you’re on, but it isn’t the only issue rising to the fore. A recent Forbes article noted that “data privacy has become one of the defining social and cultural issues of our era.” The article, which noted that “people are starting to more deeply question their growing lack of data privacy and control,” shines a glaring spotlight on today’s growing challenge of data privacy. The article reports that “roughly six-in-ten U.S. adults say they do not think it is possible to go through daily life without having data collected about them by companies or the government.”

Providing Consumers with Choice

In the face of mounting concern about censorship and privacy, BIGtoken has tackled these problems early and head on. Through a transparent platform and consumer-reward system, BIG provides consumers with choice, transparency and compensation for their data. The system also provides advertisers and media companies access to transparent, verified consumer data to better reach and serve audiences.

Available for download on the App Store and Google Play, the BIGtoken app enables its rapidly growing 16-million-plus members to choose what data they want to share, as well as which companies can buy that data and how that data is used. Users provide data by answering questions, taking surveys and connecting various online accounts. BIGtoken then anonymizes the data, sells it to brand advertisers and shares the revenue with its users.

What’s more, when BIGtoken users choose to share their data anonymously, they receive rewards in the form of cash or gift cards; they can even deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart. And users with philanthropic desires can donate their rewards to several high-profile, nonprofit associations.

BIGtoken users aren’t the only beneficiaries. Advertisers and marketers that purchase access to anonymized segments of information from BIGtoken know that the data they receive is consumer verified and in compliance with the growing number of consumer privacy acts enacted not only in the United States but around the world. BIG’s exclusive technology provides vetted data for brands in the CPG, investor relations, luxury and lifestyle verticals.

A New Era

Gig data and business analytics solutions is a booming business, one that is projected to reach $260 billion globally by next year. Those numbers make the space extremely attractive to companies with the technology, background and expertise to succeed. Launched in 2018, BIGtoken appears to be one of those companies.

Most recently, the company has added to its executive leadership strength with the appointment of crypto pioneer and digital media veteran Lou Kerner as CEO. Upon completion of the definitive agreement with Force Protection Video Equipment Corp, FPVD will be renamed BIGtoken Inc. with Kerner as CEO.

“I’ve been deeply interested in privacy since 2003 when I was running Bolt,” said Kerner. “And my interest in crypto has also been fueled, in part, by its privacy features. As the world continues to move to ensure greater internet privacy for consumers, BIGtoken is well-positioned to help brands, media companies, research organizations and political campaigns efficiently reach consumers via compliant ad targeting and surveys. I further believe BIGtoken will greatly benefit by fully embracing crypto as an alternative reward for our growing consumer base.”

The cause of data privacy is supported by BIGtoken. “Privacy is a fundamental human right whose time has come, and BIGtoken is helping lead the way, says Kerner in an article titled “The 5 Reasons I’m Joining BIGtoken as CEO.” Kerner points out that data privacy isn’t new, but the attitude shift by individuals, corporations and regulators/government is. “A new era of data privacy is, finally, upon us,” states Kerner, whose expertise in cryptocurrency and blockchain brings an added level of expertise and insight to the company.

A Delicate Balance

Companies on the front lines are trying to balance free speech and public safety while addressing issues of censorship and data privacy as solutions may be found in blockchain utilization.

Facebook Inc. (NASDAQ: FB) has developed a set of community standards that outline what is and is not allowed on Facebook. “We recognize how important it is for Facebook to be a place where people feel empowered to communicate, and we take seriously our role in keeping abuse off our service,” the company states. “Our policies are based on feedback from our community and the advice of experts in fields such as technology, public safety and human rights. To ensure that everyone’s voice is valued, we take great care to craft policies that are inclusive of different views and beliefs, in particular those of people and communities that might otherwise be overlooked or marginalized.”

Twitter Inc.’s (NYSE: TWTR) purpose is “to serve the public conversation.” The company’s guidelines note that “violence, harassment and other similar types of behavior discourage people from expressing themselves, and ultimately diminish the value of global public conversation. Our rules are to ensure all people can participate in the public conversation freely and safely.” In addition, Twitter believes that a user should “always know what data we collect from you and how we use it, and that you should have meaningful control over both.”

One of the largest U.S.-based, publicly traded Bitcoin miners in North America, Riot Blockchain Inc. (NASDAQ: RIOT) is focused on gaining exposure to the blockchain ecosystem through its cryptocurrency mining operations, internally developed businesses and joint ventures. The company’s primary focus is on Bitcoin and general blockchain technology, the same blockchain technology being used by many companies to ensure data privacy and protection.

For more information about Force Protection Video Equipment Corp (OTC: FPVD), please visit Force Protection Video Equipment Corp.

About NetworkNewsWire

NetworkNewsWire (“NNW”) is a financial news and content distribution company, one of 40+ brands within the InvestorBrandNetwork (“IBN”), that provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience comprising investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork

DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by NNW are solely those of NNW. Readers of this Article and content agree that they cannot and will not seek to hold liable NNW for any investment decisions by their readers or subscribers. NNW is a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, NNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

NNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and NNW undertakes no obligation to update such statements.

Tuesday, January 26, 2021

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Well Placed as Agricultural Biopesticides Market Expected to Grow Rapidly

 

  • Research shows that market for agricultural biopesticides expected to grow rapidly at CAGR of 14.7% until 2025
  • MustGrow providing natural plant-based biopesticide solutions for protecting plants from pests and diseases, utilizing the natural defense mechanism of the mustard plant
  • Company seems well positioned within biopesticides market expected to achieve fastest growth

The market for agricultural biopesticides is growing rapidly. The latest Markets and Markets report estimated the industry was valued at $4.3 billion in 2020 and is projected to almost double its size in the next five years — reaching $8.5 billion by 2025 and growing at a CAGR of 14.7% during the same period (https://nnw.fm/wfbEI). MustGrow Biologics (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) is well placed to capitalize on this opportunity, backed by the changing market landscape that increasingly favors natural solutions to protect agricultural crops. MustGrow’s organic biopesticide approach is plant based — harnessing the mustard seed’s natural defense mechanism to control diseases, pests and weeds.

According to the report, the use of “synthetic chemicals can lead to pollution and contamination of the soil as well as can have. . . harmful effects on the food chain.” Because of this, the report observes, there has been increasing awareness of residue-free food and a high interest in biological products.

With the change in eating habits, farmers are pressurized to shift to adopt a sustainable method of farming. Fruit and vegetable cultivation requires more investment, and with the huge infestation in fruits and vegetables both in open fields and green-houses, the demand for biopesticides is increasing. Also, to meet the export demand for residue-free crops, farmers are implementing the use of biopesticide in combination with conventional chemicals. The trend in the consumption of organic crops is also pushing farmers to adopt biopesticides.

Along with a greater awareness of biopesticides has come increasing demand for organic-grown food. “The acreage under organic cultivation for fruits and vegetables is also increasing,” the report noted. “And to achieve the standards prescribed by international exports, farmers are adopting the usage of biopesticides. To combat the harmful effects of synthetic pesticides, the government is taking initiatives in various regions by emphasizing the use of integrated pest management. Strategic developments such as expansions, new product launches, collaborations, and agreements have been adopted by the majority of key players to strengthen the market.”

The report projects that within the whole biopesticides space, the bioinsecticides segment is expected to dominate the market during the forecast period, and the fruits and vegetable segment is expected to achieve the fastest growth. The increasing pest resistance and the resurgence of crops require sustainable solutions amid regulatory ban and phase-out of some of the main ingredients.

Because of their “favorable” properties, bioinsecticides are positioned as an adequate response — they do not leave residues in the products, and they do not harm natural pests’ enemies or the environment. According to the report, the North American region is expected to drive the growth of the international biopesticides market.

The change in market demanding residue-free and organic food combined with the ever-more stringent regulatory standards in the international agricultural food supply chain is pressuring farmers to adopt a sustainable method of farming using biopesticides. As a company that operates in the robust segments of the growing biopesticides space, MustGrow is ideally positioned to benefit from these market forces.

This agriculture biotech company, which is focused on providing natural science-based biological solutions for high-value crops such as fruits and vegetables, appears poised to leverage the growing momentum favoring alternatives to synthetic chemicals. As global agriculture looks to move closer to sustainable ways of boosting yields and crop protection, MustGrow continues to position itself as an essential part of the food landscape of the future with its mustard plant-based biopesticide.

For more information, visit the company’s website at www.MustGrow.ca.

NOTE TO INVESTORS: The latest news and updates relating to MGROF are available in the company’s newsroom at https://nnw.fm/MGROF

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.